IL1B and gestational diabetes: If not controlled, the overall augmented cytokine production (stimulation of NLRP3 inflammasome and generation of IL-1β and IL-18 inflammatory cytokines [90]) during GDM may not only affect the mother but also compromise the normal development of the growing foetus, with an increased risk of serious complications for the neonate [32].